Feeds › Insider trades
Insider trades
Open-market buys and sells by officers, directors and 10% owners, from SEC Form 4. Usually filed within two business days.
About this data
- What it is
- When a company's officers, directors or owners of more than 10% buy or sell its stock, they must report the trade to the SEC on Form 4. This feed shows purchases and sales on the open market; stock grants, option exercises and shares withheld for tax are left out.
- Who files it
- The insider, usually through the company, within two business days of the trade.
- How current
- We collect new filings throughout the day on SEC business days.
- Worth knowing
- Sales are often routine: insiders sell to diversify, to pay taxes, or under a 10b5-1 plan set up months in advance. A purchase with their own money is less common, which is why many investors pay closer attention to it.
All of this comes from public filings.
Source and freshness · Information, not investment advice (disclaimer).
Open-market trades per day, last 30 days
Purchases Sales
By trade date. Insiders have two business days to file, so the most recent days fill in later.
Latest open-market insider trades
Showing: ticker TARS
| Traded | Insider | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Sep 15, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 66 | $80.01 | $5,281 Sale | Form 4 ↗ |
| Sep 15, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 759 | $79.00 | $60.0K Sale | Form 4 ↗ |
| Sep 15, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 11,675 | $78.33 | $914.5K Sale | Form 4 ↗ |
| Sep 4, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,590 | $90.00 | $143.1K Sale | Form 4 ↗ |
| Sep 4, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,590 | $85.00 | $135.2K Sale | Form 4 ↗ |
| Sep 4, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,386 | $90.00 | $484.7K Sale | Form 4 ↗ |
| Sep 4, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,387 | $85.00 | $457.9K Sale | Form 4 ↗ |
| Sep 4, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,900 | $91.27 | $264.7K Sale | Form 4 ↗ |
| Sep 4, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 7,100 | $90.27 | $640.9K Sale | Form 4 ↗ |
| Sep 4, 2026 | Seshadri Neervannan Chief Operating Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,564 | $85.00 | $387.9K Sale | Form 4 ↗ |
| Sep 2, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,590 | $80.00 | $127.2K Sale | Form 4 ↗ |
| Sep 2, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,387 | $80.00 | $431.0K Sale | Form 4 ↗ |
| Sep 2, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 10,000 | $80.06 | $800.6K Sale | Form 4 ↗ |
| Sep 1, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,601 | $73.86 | $339.8K Sale | Form 4 ↗ |
| Jun 17, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,418 | $61.81 | $334.9K Sale | Form 4 ↗ |
| Jun 17, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,582 | $61.24 | $280.6K Sale | Form 4 ↗ |
| Jun 16, 2026 | Jeffrey S. Farrow See Remarks | TARS Tarsus Pharmaceuticals, Inc. | Sale | 14,396 | $60.95 | $877.4K Sale | Form 4 ↗ |
| Jun 15, 2026 | Katherine Goodrich Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,954 | $62.08 | $183.4K Sale | Form 4 ↗ |
| Jun 15, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 1,928 | $62.94 | $121.3K Sale | Form 4 ↗ |
| Jun 15, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 10,572 | $61.97 | $655.1K Sale | Form 4 ↗ |
| Mar 20, 2026 | Seshadri Neervannan Chief Operating Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,989 | $66.75 | $199.5K Sale | Form 4 ↗ |
| Mar 19, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 390 | $67.00 | $26.1K Sale | Form 4 ↗ |
| Mar 19, 2026 | Bryan Wahl General Counsel | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,231 | $67.00 | $283.5K Sale | Form 4 ↗ |
| Mar 19, 2026 | Dianne C. Whitfield Chief Human Resources Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,174 | $67.00 | $279.7K Sale | Form 4 ↗ |
| Mar 19, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 11,964 | $67.00 | $801.6K Sale | Form 4 ↗ |
| Mar 19, 2026 | Seshadri Neervannan Chief Operating Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,589 | $67.00 | $307.5K Sale | Form 4 ↗ |
| Mar 19, 2026 | Aziz Mottiwala Chief Commercial Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,440 | $67.00 | $297.5K Sale | Form 4 ↗ |
| Mar 19, 2026 | Jeffrey S. Farrow See Remarks | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,186 | $67.00 | $146.5K Sale | Form 4 ↗ |
| Mar 18, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 379 | $68.71 | $26.0K Sale | Form 4 ↗ |
| Mar 18, 2026 | Bryan Wahl General Counsel | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,125 | $68.71 | $283.4K Sale | Form 4 ↗ |
| Mar 18, 2026 | Dianne C. Whitfield Chief Human Resources Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,071 | $68.71 | $279.7K Sale | Form 4 ↗ |
| Mar 18, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 11,667 | $68.71 | $801.6K Sale | Form 4 ↗ |
| Mar 18, 2026 | Seshadri Neervannan Chief Operating Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,610 | $68.71 | $248.0K Sale | Form 4 ↗ |
| Mar 18, 2026 | Aziz Mottiwala Chief Commercial Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,330 | $68.71 | $297.5K Sale | Form 4 ↗ |
| Mar 18, 2026 | Jeffrey S. Farrow See Remarks | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,133 | $68.71 | $146.6K Sale | Form 4 ↗ |
| Mar 17, 2026 | Elizabeth Yeu Lin Chief Medical Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 375 | $69.42 | $26.0K Sale | Form 4 ↗ |
| Mar 17, 2026 | Bryan Wahl General Counsel | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,084 | $69.42 | $283.5K Sale | Form 4 ↗ |
| Mar 17, 2026 | Dianne C. Whitfield Chief Human Resources Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,029 | $69.42 | $279.7K Sale | Form 4 ↗ |
| Mar 17, 2026 | Bobak R. Azamian President/CEO and Board Chair, Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 10,972 | $69.42 | $761.7K Sale | Form 4 ↗ |
| Mar 17, 2026 | Seshadri Neervannan Chief Operating Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,125 | $69.42 | $216.9K Sale | Form 4 ↗ |
| Mar 17, 2026 | Aziz Mottiwala Chief Commercial Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 4,286 | $69.42 | $297.5K Sale | Form 4 ↗ |
| Mar 17, 2026 | Jeffrey S. Farrow See Remarks | TARS Tarsus Pharmaceuticals, Inc. | Sale | 2,111 | $69.42 | $146.5K Sale | Form 4 ↗ |
| Mar 16, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 493 | $69.75 | $34.4K Sale | Form 4 ↗ |
| Mar 16, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 8,378 | $69.03 | $578.3K Sale | Form 4 ↗ |
| Mar 16, 2026 | William J. Link PhD Director | TARS Tarsus Pharmaceuticals, Inc. | Sale | 3,629 | $68.09 | $247.1K Sale | Form 4 ↗ |
| Mar 4, 2026 | Seshadri Neervannan Chief Operating Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 8,366 | $76.67 | $641.4K Sale | Form 4 ↗ |
| Jan 2, 2026 | Dianne C. Whitfield Chief Human Resources Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 893 | $82.93 | $74.1K Sale | Form 4 ↗ |
| Jan 2, 2026 | Dianne C. Whitfield Chief Human Resources Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 835 | $81.90 | $68.4K Sale | Form 4 ↗ |
| Jan 2, 2026 | Dianne C. Whitfield Chief Human Resources Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 8,122 | $80.71 | $655.5K Sale | Form 4 ↗ |
| Jan 2, 2026 | Dianne C. Whitfield Chief Human Resources Officer | TARS Tarsus Pharmaceuticals, Inc. | Sale | 5,715 | $80.09 | $457.7K Sale | Form 4 ↗ |
The newest 50 items, most recent first. Every row links to its original filing. Updated Nov 15, 2026, 5:06 PM EST.
Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.
Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · Clinical trial updates · FDA approvals and clearances